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ABSTRACT 
For more than two decades, the opioid epidemic has swept through the United States and 
has caused thousands of deaths every year due to opioid overdose.  The Centers for 
Disease Control and Prevention (CDC; 2019) has reported that since 1999, over 770,000 
Americans have died from overdoses.  Nearly 70% of deaths in 2018 were due to opioids, 
47% of which were the result of fentanyl or a non-methadone opioid and 22% were the 
result of heroin (CDC, 2019).  As policy and treatment protocols attempt to manage those 
who seek treatment, the pharmaceutical industry has developed a life-saving medication 
that gives those who overdose another chance at recovery.  Despite legislation allowing 
standing prescriptions and statewide access to naloxone, there continues to be some 
disconnect toward getting the layperson to be willing to intervene.  The present study 
computed bivariate correlations and logistic regressions to identify factors that predict a 
person’s likelihood of administering naloxone should he or she encounter a person who 
has overdosed.  An online survey was completed by 129 college students of various 
demographics.  Factors examined included concern of legal and civil ramification, 
empathy, stigma toward substance use, and personal attribution of addiction.  Results 
indicated the strongest predictor to be empathy.  These findings can be used to inform 
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CHAPTER 1: INTRODUCTION 
Statement of the Problem 
The opioid epidemic is a national health concern that plagues many Americans.  
The National Institute on Drug Abuse (NIDA; 2019) has estimated that 72,000 
Americans died in 2017 from opioid overdoses.  As the number of deaths due to overdose 
increases, policymakers and public health officials continue to find ways to mitigate this 
problem.  In September 2016, the United States Attorney General issued a memorandum 
identifying a three-pillar strategy to combat the opioid epidemic.  The primary pillar was 
prevention, which included prevention of overdose deaths through the utilization of 
naloxone.  In recent years, there have been a variety of strategic efforts launched to help 
combat the opioid epidemic.  As the efforts have increased to get naloxone into the hands 
of the public, it is important to identify factors that increase its utilization when one 
encounters someone who has overdosed.  
Purpose of the Study 
This study aimed to identify individual characteristics of a person that impact his 
or her likelihood of administering naloxone.  The study accomplished this by presenting 
participants with a vignette in which they were presented an opportunity to administer 
naloxone and examining their decided courses of action, degree of empathy, stigma 
toward addiction, concern of legal/civil ramifications, and personal attributions of 
addiction.  
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The results of this study aimed to provide insight into the characteristics that may 
increase or reduce the likelihood of someone administering naloxone in the event of an 
opioid overdose.  The study intended to provide useful information to guide future 
research and policy regarding more targeted and impactful naloxone training and 
distribution.  The purpose of this study was to identify factors that may make people 
resistant to administering naloxone in the event they encounter someone who is 
experiencing an opioid overdose.   
Research Questions and Hypotheses 
Hypothesis 1.  Participants with higher level of empathy were hypothesized to be 
significantly more likely to administer naloxone.  
Hypothesis 1 rationale.  Leading research notes empathy as an “other-person 
oriented emotion that evokes altruistic motivation to reduce other’s needs” (Batson, 
Duncan, Ackerman, Buckley, & Birch, 1981).  Both empathy and feelings of personal 
distress have been found to impact an individual’s decision to perform helping behaviors 
(Batson et al., 1981).  When feelings of personal distress outweigh empathy, helping 
behaviors are decreased (Carrera et al., 2012).  It was hypothesized that when a person is 
trained in the proper administration of naloxone, his or her empathy would outweigh 
feelings of personal distress and facilitate the decision to perform helping behaviors by 
administering the naloxone.  
Hypothesis 2.  Participants with lower levels of stigma toward opioid users were 
hypothesized to be significantly more likely to administer naloxone. 
Hypothesis 2 rationale.  Research has suggested that fear of encountering social 
stigma is correlated with a decreased likelihood of calling 911 in the event of 
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encountering an overdose, despite Good Samaritan Laws in place (Latimore & Bergstein, 
2017).  Examining whether this factor extends to the decision to administer naloxone was 
intended to provide insight into how the decision to intervene is made.  
Hypothesis 3.  Participants with a lower level of concern regarding legal/civil 
ramifications were hypothesized to be significantly more likely to administer naloxone.  
Hypothesis 3 rationale.  Research indicates that despite establishment and 
education around Good Samaritan Laws, people are still hesitant to involve law 
enforcement if they encounter individuals who have overdosed (Koester, Mueller, 
Raville, Langegger, & Binswanger, 2017).  It is important to establish the degree that 
legal or civil concerns may impede naloxone administration for future research to 
examine how the public can come to accept and trust the immunity granted by Good 
Samaritan Laws. 
Hypothesis 4.  Participants with a significantly lower degree of negative 
attribution toward those who use opioids were hypothesized to be more likely to 
administer naloxone.  
Hypothesis 4 rationale.  Research demonstrates a continued lack of 
understanding regarding the conceptualization of addiction as a disease, as well as 
support of the idea that habitual drug use is the result of free will (Vonasch, Clark, Lau, 
Vohs, & Baumeister, 2017).  Research is unclear about whether those who believe drug 
use is due to a moral failing and a result of free would support overdose reversal efforts.  
Research can definitively state that majority of Americans in today’s society support 
some efforts toward combating the opioid epidemic (Barry et al., 2016).  It was 
hypothesized that those who have a low degree of negative attribution, or belief that the 
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individual’s drug use is outside the scope of free will, would choose to administer 
naloxone.  This hypothesis was formulated on the assumption that those who have a 
negative attribution toward those using drugs do so because they believe those with 
substance use disorders are using solely because of their own poor decisions.  
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CHAPTER 2: REVIEW OF THE LITERATURE 
People have found ways to use substances to alter their stages of consciousness 
since the beginning of time.  Psychoactive drug use can be traced back to the prehistoric 
period of 8500-4000 B.C. when humans utilized plants and fruits for their psychoactive 
properties (Inaba & Cohen, 2007).  The most popular mind- and mood-altering 
substances have stayed consistent for centuries, including tobacco leaves, the cannabis 
plant, team leaves, coca leaves, fruits that ferment into alcohol, and opium poppies 
(Austin, 1979).  
There has been evidence of opium use in ancient Greece, Spain, Egypt, and 
Mesopotamia (Escohotado, 1999).  Early Mesopotamians used opium for its medicinal 
and psychological properties.  It is believed that the plant was used for pain relief, cough 
suppression, euphoria, and sedation (Hoffman, 1990).  Historical evidence for substance 
use demonstrates the human tendency to use mind-altering materials to achieve physical 
or psychological effects.  The propensity to alter the state of mind lays the foundation for 
the substance use seen in current society, specifically the opioid epidemic.  Smoking 
opium is a practice that dates to the year 1500, when Portuguese traders introduced the 
practice to the Chinese people (Inaba & Cohen, 2007).  Many years later, Chinese 
immigrants brought smoking opium to the United States, introducing opium dens to the 
west coast (Kuhn, Swartzwelder, & Wilson, 2003).  
Opioids are a class of drug that includes both natural (opiates) and synthetic 
(opioid) substances that act on the brain’s opioid receptors.  The term opioid is used to 
encompass natural, synthetic, and semi-synthetic forms of the substance.  The opioid 
class of drugs includes common “street” drugs, such as heroin, in addition to medications 
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such as morphine, fentanyl, hydrocodone, and oxycodone.  The effects of opioids include 
pain relief, analgesic properties, sedation, euphoria, reduced heart rate, and depressed 
breathing.  There have been four opioid receptors identified in the human brain: MOP (µ 
= mu), KOP (κ = kappa), DOP (δ = delta), and NOP-R (Waldhoer, Bartlett, & Whistler, 
2004).  These receptors are naturally occurring and well distributed throughout the body 
to accommodate the body’s endogenous pain-relieving processes.  When an opioid is 
introduced into the body by way of any route of administration that allows it to cross the 
blood-brain barrier, it binds to one of the four receptors and produces the effects.  An 
opioid overdose occurs when an abundance of the substance is introduced into the body 
producing toxic effects.  NIDA and the CDC concentrate the discussion of the opioid 
epidemic to prescription opioid use, heroin, and the recent development of fentanyl use.  
Scope of the Opioid Epidemic 
The National Survey on Drug Use and Health estimated that in 2017, 3.1% of 
individuals between the ages of 12 and 17, 7.2 % of those ages 18 to 25, and 3.7% of 
individuals 26 or older were prescribed opioids for pain relief (Center for Behavioral 
Health Statistics and Quality, 2017).  NIDA (2019) has identified that prescription 
opioids have a high potential for abuse and modes of misuse include taking the 
medication at a different dosage or route of administration than prescribed, taking opioids 
prescribed to another person, or taking the medication for the purpose of an obtaining 
altered mind or mood.  Commonly prescribed opioids for severe pain include 
hydrocodone (Vicodin), oxycodone (OxyContin, Percocet), oxymorphone (Opana), 
morphine, codeine, and fentanyl.  In 2010, the CDC reported that 81.2 per 100 Americans 
were given prescription opioids for pain.  Despite efforts to combat the epidemic, in 2017 
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there were 58 opioid prescriptions written for every 100 Americans and more than 17% 
of Americans had at least one opioid prescription filled (CDC, 2018).  Despite the 
decrease in percentage of opioid prescriptions written from 2010 to 2017, 58 per 100 
Americans equates to 191 million opioid prescriptions in one year alone.  It has been 
found that as many as 80% of Americans who reported using heroin identified that their 
use began with prescription opioids (Muhuri, Gfroerer, & Davies, 2013).  
Approximately 2.2% of adults over the age of 26 reported use of heroin within 
their lifetimes according to the 2018 National Survey on Drug Use and Health.  The same 
survey reported 1.8% of those in the 18 to 25 age bracket had used heroin.  The 
prevalence of heroin use among Americans has been growing since 2007 (Center for 
Behavioral Health Statistics and Quality, 2017).  Heroin can be used via many routes of 
administration, including snorted, injected, or smoked.  As previously identified, heroin is 
commonly, but not always, the result of progressive substance use (Muhuri et al., 2013).    
Illicit fentanyl use continues to gain attention in the discussion of the opioid 
epidemic.  Fentanyl is a synthetic opioid 50 to 100 times more potent than morphine and 
is typically used to manage pain for patients after surgery (NIDA, 2016).  In recent years, 
the number of overdose deaths attributed to synthetic opioids, identified by the CDC as 
being predominantly fentanyl, has grown exponentially.  Provisional data for the year 
2017 report 29,406 deaths attributable to this classification of opioids.  This is a 10,000 
increase from the 19,413 reported in 2016, and a 20,000 increase from the approximately 
10,000 deaths reported in 2015 (CDC, 2018).  Fentanyl can be particularly dangerous due 
to its high potency and ability to be mixed into other substances without the user’s 
knowledge. 
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Opioid-dependent patients are more likely to have HIV, hepatitis C, lower back 
pain, posttraumatic stress disorder, psychotic symptoms, and diagnoses of alcohol, 
cocaine, or amphetamine use disorders (Barnett, 2009).  An increase in likelihood of 
other medical conditions results in increased health care costs for this population of 
Americans.  It has been established that high-risk prescription opioid users have higher 
health care costs and utilization records than non-users (Chang, Kharrazi, Bodycombe, 
Weiner, & Alexander, 2018).  A “value of statistical life” analytic method estimated the 
true cost to society is $504 billion dollars, including work-productivity, earnings, and 
raising families (Ryan, 2018).  According to a 2016 analysis of the 2013 calendar year, 
the economic burden of the opioid epidemic is $78.5 billion (Florence, Zhou, Luo & Xu, 
2016).  Florence and colleagues (2016) identified over $28 billion of this sum was 
accounted for by health care and substance abuse treatment and $7.7 billion was 
attributable to criminal justice-related costs.  It can be assumed that these numbers will 
continue to grow with the growing number of opioid users.  
In 2013, the Office of National Drug Control Policy (ONDCP) released a joint 
statement with the Substance Abuse and Mental Health Services Association (SAMHSA) 
regarding an “Opioid Toolkit,” which promoted the use of naloxone outside of medical 
settings (ONDCP & SAMHSA, 2013).  These agencies advocated for law enforcement 
officers and laypersons to possess and carry naloxone to assist in the event of overdoses.  
Despite the recommendation for law enforcement officers to be trained and equipped 
with naloxone, some reports have demonstrated the rate of implementation remains low 
(Dudzik, 2017).  The Surgeon General has extended the recommendation to include 
opioid users’ loved ones to have naloxone in their homes (U.S. Surgeon General, 2018).  
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Treatment Approaches 
The need for substance use treatment has been present since humans began using 
mind- and mood-altering substances.  Just as ancient records indicate that people used 
various substances for mind-altering experiences, records also indicate the historical need 
for treatment.  Ancient Egyptians recorded those with alcoholism being sanctioned to 
private homes, and the Ancient Romans and Greeks recorded treating substance use with 
asylums (White, 1998).  Since ancient times, treatment has continued to evolve.  The 
evolution of treatment can be broken down into treatment based on the moral model, the 
12-Step approach, and medication-assisted treatment.  
Moral model. The initial stages of treatment in America can be traced back to the 
practices of incarceration.  Those labeled “drunkards” were typically placed in jail for 
their behaviors (Rosenberg, 1995).  Societal practices of incarceration as a result of 
misusing alcohol was somewhat counterintuitive given records of alcohol being provided 
to inmates in prisons (Rothman, 2001).  This practice demonstrated the lack of 
knowledge regarding a logical explanation for the behaviors of those misusing 
substances.  The passing of the Harrison Narcotics Tax Act in 1914 reinforced this belief 
by heavily regulating opium and coca products (Inaba & Cohen, 2007).  Prior to the 
passing of this law, opium and coca products were widely used to treat morphine and 
alcohol addiction (Henniger & Sung, 2014).  Regulating these practices contributed to the 
moral model by implying that addiction should be criminalized due to the illegalization 
of the substances used to treat addiction-related behaviors.  The American Association 
for the Cure of Inebriation was the first organization to attempt to transition the treatment 
of addiction to a professional service when proponents advocated that addiction should be 
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treated as a disease rather than a criminal act that should be punished (Henniger & Sung, 
2014).  
Mutual assistance programs.  Although mutual assistance programs, such as 
Alcoholics Anonymous (AA), Narcotics Anonymous, and other 12-step programs, are 
not widely considered to be evidenced-based interventions, they are often used as 
ancillary services within other treatment programs.  These 12-step programs were not the 
first self-help groups in America, but they have a strong presence in the development of 
recovery from substance use.  AA began after prohibition led to the disappearance of 
many formal modalities of treatment (White, 1998).  The Big Book of Alcoholics 
Anonymous states, “half measures have availed us nothing,” encouraging those looking 
for sobriety to follow the 12 steps to make a complete lifestyle change incorporating 
spiritual principles (AA, 2014).  The 12 steps encourage newcomers to adhere to the 
guidance of sponsors, those who have had success with the steps in their own recovery 
journeys, to make the lifestyle changes necessary to combat the disease of addiction and 
abstain from drug use.  The Big Book refers to alcohol and other drug addictions as an 
allergy, noting those who are addicted cannot tolerate the effects without developing a 
dependence, like the “non-addict” (AA, 2014).  
Medication-assisted treatment.  Medication-assisted treatment (MAT) is used to 
define any modality of treatment that combines pharmaceutical intervention within a 
holistic treatment plan developed for a patient’s substance dependence (SAMHSA, 
2020).  SAMHSA (2020) has advised that FDA-approved medications should be initiated 
and monitored by trained physicians in combination with other evidenced-based practices 
for substance use.  
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The historical roots of MAT in the United States can be traced to the 1800s when 
cocaine was utilized to treat alcoholism and morphine addiction (White, 1998).  In China, 
morphine (an opiate) was used to treat opium addiction, and in Europe, heroin was 
developed to treat morphine addiction (Inaba & Cohen, 2007).  Despite the development 
of this treatment approach, MAT is not currently used as a replacement for the original 
substance but, rather, to adequately manage both acute and protracted withdrawal 
symptoms and cravings to allow the individual to fully participate in the necessary 
therapy (SAMHSA, 2020).  
Currently, there are three FDA approved medications that are used for the 
treatment of opioid use disorder (OUD).  These include methadone, a synthetic opioid 
receptor agonist, buprenorphine-naloxone (sold under the brand names Suboxone and 
Subutex) which acts as a partial agonist, and naltrexone (sold under the brand name 
Vivitrol) which acts as a full opioid antagonist.  Naltrexone can be given via a daily oral 
pill or a once monthly intramuscular injection (NIDA, 2019).  The availability of MAT 
has been found to decrease illicit opioid use, criminal activity, and the transmission of 
infectious disease (Mattick, 2014; Mattick, Breen, Kimber, & Davoli., 2009; Schwartz et. 
al., 2013).  
Research has shown that MAT is most effective when combined with 
psychosocial intervention.  It has been demonstrated that methadone maintenance and 
cognitive behavioral therapy are effective; however, little research has been done on 
other types of MAT and modalities of therapy (Dugosh et al., 2016). 
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Overdose Reversal 
Despite many interventions and treatment modalities that have been used with 
varying degrees of success, most recent research indicates that more than 72,000 
overdose deaths due to opioid use occurred in 2017 (NIDA, 2019).  Naloxone (sold 
commonly under the brand name Narcan) was developed to reverse an occurrence of an 
opioid overdose and can be used to save a life during an emergent situation.  
Naloxone is an opioid antagonist that binds to the brain’s opioid receptors and 
reverses the physical effects of an overdose.  When the physical effects of an overdose 
are reversed, the person immediately experiences symptoms of opioid withdrawal.  This 
reversal will restore normal breathing and other bodily functions and can be used with all 
drugs within the opioid class (NIDA, 2019).  If naloxone is given to an individual who 
does not have opioids in his or her system, there will be no effect.  Naloxone is a short-
acting medication that wears off in 20 to 90 minutes (harmreduction.org, 2020).  Because 
of the short-acting nature, it is important to get the individual to an emergency 
department after being given any amount of naloxone because he or she may need 
additional doses after the initial dose wears off (NIDA, 2019).   
NIDA (2019) identified three possible administrations of naloxone: injectable, 
auto-injectable, and nasal spray.  The Food and Drug Administration (FDA) requires the 
injectable form to be administered by trained medical professionals, whereas it 
recommends the auto-injectable and nasal spray for laypeople with appropriate training 
(FDA, 2016).  
Naloxone is becoming more widely distributed among first responders and the 
public.  Permissions for the overdose reversal are dependent on state laws; however, 
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states are passing legislation to provide the drug to the public.  Legislation is supported 
by the recommendation by the ONDCP for any member of the public to be trained and 
obtain naloxone if a loved one or family member is at risk for an opioid overdose 
(ONDCP & SAMHSA, 2013).  Standing orders are being established in most states in the 
U.S. to make naloxone more available to the public.  A standing order is legislation that 
allows a licensed physician to designate a trained layperson as outlined above to obtain 
naloxone (University of Maryland, 2016).  This allows the public to access naloxone 
without facetime with the physician.  A statewide standing order, such as the model used 
in Pennsylvania, allows the public to access naloxone “from a pharmacy in the event they 
are unable to obtain naloxone or a prescription for naloxone from their regular health care 
provider” (Pennsylvania Department of Health, 2018).  Forty-two states and the District 
of Columbia have statewide standing orders (Kokosky, 2018).  According to SAMHSA, 
every state in the U.S., excluding Nebraska, have models of non-patient-specific 
practices, such as standing orders or third-party prescribing privileges (SAHMSA, 2018).   
Recent research has demonstrated that education regarding the use and 
availability of naloxone within treatment settings is helpful in its distribution to substance 
users.  Psychoeducation regarding the distribution and use of naloxone increases 
knowledge of proper procedure in the event of an opioid overdose (Lott & Rhodes, 
2006).  Some individuals identified naloxone to be “just as important as a clean needle” 
to their using rituals and some individuals demonstrated very low knowledge of the 
availability of the lifesaving drug (Heavey et al., 2018).  Resistance toward carrying 
naloxone by individuals using opioids varies from the size of the kit to reporting no 
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longer being around other people who are using drugs (Khatiwoda, R. Proeschold-Bell, 
Meade, Park, & S. Proeschold-Bell, 2018). 
Possible Barriers to Naloxone Administration   
Although it continues to be distributed more broadly and more individuals are 
being trained on administration, many individuals continue to experience resistance to 
obtaining and utilizing naloxone if encountering overdoses.  In addition to bystander 
hesitancy, medical professionals have their own hesitancy toward prescribing naloxone to 
substance using individuals.  Hesitancies have been found to include concerns of lack of 
knowledge, third-party education, fear of enabling drug use, and stigma against those 
who use opioids (Gatewood, Van Wert, Andrada, & Surkan, 2016).  It is important to 
consider providers’ apprehensions toward prescribing naloxone as these practices are 
likely to trickle down to public consumers.  
Knowledge and attitudes.  Despite better training and distribution efforts, many 
people are unaware of naloxone and have yet to be trained.  A lack of knowledge can 
make efforts to combat the epidemic futile by allowing stigma and misperceptions to 
continue.  People continue to view addiction as a loss of free will (Vonasch et al., 2017). 
This view can undermine the recovery efforts of those using drugs, as well as the efforts 
of those in the field of treating addicted individuals.  
Just as the presence of stigma and lack of knowledge can deter efforts to combat 
the epidemic, support of the cause can increase efforts.  A majority of Americans 
recognize the severity of the opioid epidemic and support the efforts to address this 
national problem (Barry et al., 2016).  It is imperative this support is harnessed with 
appropriate knowledge to include the general population in the efforts to spread recovery.  
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Having the support of the general population is essential to progressing to the 
involvement of the public in efforts to combat the epidemic.   
Concern of legal ramifications.  As evidence demonstrates a lack of 
understanding of substance use, it is possible there is a lack of knowledge surrounding 
the legal ramifications of administering naloxone.  If a lack of knowledge is present, it is 
possible an individual may have a fear of legal implication if he or she becomes involved 
in a situation relating to an opioid overdose.  It is possible this fear begins with hesitation 
by physicians in prescribing naloxone.  Research continues to demonstrate physician 
apprehension for fear of legal ramifications despite minimal risk (Burris, Norland, & 
Edlin, 2001; Davis, Carr, Southwell, & Beletsky, 2015).  If the people are concerned 
about legal action in response to administering naloxone, they may continue to be 
hesitant to utilize the drug despite training and availability.  For instance, an individual 
may be concerned about his or her own legal implications due to the presence of 
paraphernalia on the scene of an overdose.  
Many states have established Good Samaritan Laws to assist with this fear.  The 
National Conference of State Legislatures (2017) reported that 40 states and Washington 
D.C. have some form of a Good Samaritan Law that protects those who call emergency 
medical professionals for overdoses.  Research has shown that fear of repercussions 
persists despite the presence and knowledge of Good Samaritan Laws in the instances of 
drug overdoses (Koester et al., 2017). 
Empathy and stigma.  In the presence of available naloxone, appropriate 
training, and adequate knowledge regarding drug use and applicable legislation, a person 
encountering an individual who has overdosed needs to make a decision about whether to 
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intervene.  It is possible this decision is made based on the person’s level of empathy.  
The presence of stigma toward drug using individuals may cause a lack of empathy 
toward this population and may deter an individual from intervening. 
A lack of empathy and feelings of futility have been demonstrated in first 
responder populations when intervening in recurrent cases of drug overdoses (Green et 
al., 2013).  It is possible this phenomenon permeates the public as well.  If an individual 
experiences a lack of empathy and feelings of futility toward efforts to combat the opioid 
epidemic, he or she may not have motivation to get training or to carry naloxone, 
ultimately preventing him or her from intervening in an instance of overdose.  
Research demonstrates that increased empathy toward a member of a stigmatized 
group ultimately increases the empathy toward the group (Batson, Polycarpou, et al., 
1997).  If it is identified that empathy is a contributing factor to a person’s decision to 
administer naloxone, it would be imperative to help decrease stigma and raise the levels 
of empathy for this population.   
Given this data, the present study aimed to identify factors that impact an 
individual’s decision to administer naloxone upon encountering a person who is 
experiencing an opioid overdose.  
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CHAPTER 3: METHOD 
The purpose of this study was to identify factors that may make people resistant to 
administering naloxone in the event they encounter someone who has overdosed. 
Participants were asked to complete a demographic questionnaire, analyze a vignette, and 
complete three measures.  A within-group, correlational design was used in this study.  
The results of this study were interpreted using a logistic regression.  
Participants 
The participants in this study were students in undergraduate universities and 
trade/technical schools (N = 130).  Participants were recruited for this study through a 
sample of convenience using an online student listserv.  The students were not 
compensated for their participation; however, all participants were entered in a drawing 
to win one of four $25.00 Amazon gift cards.  
Inclusion and exclusion criteria.  Individuals were permitted to participate in 
this study if they were 18 years of age and older, students in undergraduate or 
technical/trade schools, had access to computers, and were willing to participate in the 
survey.  Individuals were excluded from this study if they were under 18 years of age, 
had a non-student status, and were unwilling to participate in the study.  Naloxone 
training was used as a hypothetical in the vignette; therefore, training was not a 
requirement to participate in the study.  
Measures 
Six instruments were used in this online inquiry: (a) demographic and personal 
history questionnaire, (b) vignette, (c) Toronto Empathy Questionnaire, (d) Affect Scale 
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for Substance Users, (e) Likert-type scale regarding concern of legal/civil ramifications, 
and (f) Modified Attributions of Obesity Scale (AOAS). 
Demographic and personal history questionnaire.  Participants were given a 
demographic questionnaire developed by the researcher.  Demographic information 
collected by this questionnaire included gender, age, ethnicity, socioeconomic status, 
exposure to substance use disorders, and whether the participant has had a loved one 
revived with naloxone. 
Vignette.  Participants were asked to read a vignette detailing an experience in 
which they encountered someone who was demonstrating symptoms of an opioid 
overdose.  The vignette informed the participant that he or she has been trained in the use 
of naloxone and has it available to him or her at the time he or she encounters the 
individual who has overdosed.  After the vignette, the participant was asked to indicate 
his or her next actions in the scenario.  Potential answers included “administer naloxone,” 
“ask someone else to administer the naloxone,” “call 911,” “ensure a witness calls 911,” 
or “not get involved.”  After indicating his or her next course of action, the participant 
was asked to rate his or her confidence that this choice would match his or her actions 
should this situation be encountered outside of an imaginal circumstance.  
Toronto Empathy Questionnaire.  The third measure used in this study was the 
Toronto Empathy Questionnaire (TEQ; Spreng, McKinnon, Mar, & Levine, 2009).  This 
is a self-report measure that measures attributes associated with empathy.  Items 1 and 4 
measure the perception an individual has of the emotional state of another person.  Item 8 
assesses emotion comprehension in others.  Items 2, 7, 10, 12 ,and 15 measure emotional 
states in others by indexing the frequency of behaviors.  Items 3, 6, 9, and 11 gauge 
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physiological arousal.  Items 5, 14, and 16 measure altruism.  Item 13 is indicative of 
higher-order empathy, such as prosocial behavior (Spreng et al., 2009).  
The TEQ is a series of 16 statements in which participants are asked to rate how 
frequently they feel or act as the statement describes.  The TEQ is scored using the 
following rating: Never = 0, Rarely = 1, Sometimes = 2, Often = 3, Always = 4.  The 
higher the score, the more empathy the participant demonstrates (Spreng et al., 2009).  
The TEQ correlated positively with the Empathy Quotient, r = .80, p < .01 and 
negatively with the Autism Quotient, r = -.33, p <.01 (Spreng et al., 2009).  The TEQ 
demonstrated internal consistency of α =.87 and high test-retest reliability, r =.81, p < 
.001 (Spreng et al., 2009).  
Affect Scale for Substance Users.  The Affect Scale for Substance Users (AS-
SU) is a scale designed to measure the amount of stigma the participant has toward 
someone using mind- and mood-altering substances (Brown, 2011).  Brown (2011) found 
the internal consistency for this measure to be α = .92.  This measure was originally 
adapted from three measures of mental illness stigma, the Social Distance Scale, the 
Dangerousness Scale (Link, Cullen, Frank, & Wozniak, 1987), and the Affect Scale 
(Penn et al., 1994).  The AS-SU measures the level of stigma a participant has for an 
addicted person by inquiring about factors such as his or her comfort with interacting 
with someone with a substance use disorder, perception of his or her personality, and 
types of emotions toward an addicted person.  The author advised that in subsequent 
research, the phrase “substance use disorder” should be substituted with the specific 
substance of interest due to research indicating that stigma can vary based on substance 
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(Brown, 2011).  Because of this, “substance use disorder” was changed to “opioid use 
disorder” for the purpose of this study.  
Likert-scale regarding civil and legal concerns.  Two items were measured 
using a Likert-like scale.  In the first item, participants were asked to rate their concern 
regarding legal action in retaliation for using naloxone.  In the second item, participants 
were asked to rate the same level of concern; however, they were asked to identify their 
level of concern with civil action.  
Modified Attributions of Obesity Scale.  The Attributions of Obesity Scale 
(Foster et al., 2003) was developed to assess physicians’ attitudes toward obese patients.   
This measure consists of multiple sections inquiring about physician characteristics and 
viewpoints in working with obese patients.  The sections of this measure examine 
physicians’ characteristics (heights and weight, type of practice, income level of typical 
patient) and case conceptualization questions regarding patients with the presenting 
problem of obesity.  The final two sections of this assessment ask the physician about his 
or her attributions of obesity and characteristics he or she attributes to obese patients. 
These final two sections were adapted for this study, to form the Attributions of 
Addiction Scale (AOAS).  
In the first adapted section, participants were asked to provide a Likert-rating of 1 
(Strongly Disagree) to 5 (Strongly Disagree) to measure how much their beliefs are in 
accordance with each statement.  The wording of these items were changed from “obese 
patients” to “addicted persons.”  The following items were eliminated due to the inability 
to be adapted from physician rating to layperson and/or from obesity to addiction: “I 
make accommodations for obese patients by providing big thigh cuffs, large hospital 
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gowns, and armless chairs,” “I am usually unsuccessful in helping obese patients lose 
weight,” “I would spend more time working on weight management issues with patient if 
my time was reimbursed appropriately,” “A 10% reduction in body weight is sufficient to 
improve of control obesity-related health complications,” and “Physicians should be role 
models by maintaining normal weight.”  
The second adapted section asked the participant to rate their beliefs about 
characteristics of obese patients on a 7-point Likert scale.  The items consist of 15 pairs 
of opposite adjectives (e.g., bad/good, compliant/noncompliant, weak-willed/strong-
willed).  The directions for this section inform the participant the adjectives are 
commonly used to describe “obese patients.”  The wording of these instructions was 
adapted to state the adjectives are used to describe “addicted persons.” 
Procedure 
Prior to dissemination, IRB approval was obtained at Philadelphia College of 
Osteopathic Medicine (PCOM).  A document containing the information regarding the 
study and raffle, the demographic questionnaire, the vignette, the TEQ, the AS-SU, the 
Likert-items regarding civil and legal concern, and the Modified Attributions of Obesity 
Scale (Attributions of Addiction) were created.  The information were uploaded to 
Research Electronic Data Capture (REDCap) with consideration for order effect of the 
included measures.  Undergraduate students were recruited via social media groups for 
college students, where posts were created to inquire about their interest to participate in 
this study.  The inquiry included the REDCap link.  When interested students clicked the 
link, they saw a page that thanked them for their participation and a detailed description 
of the study and what they were being asked to do.  Participants were informed about the 
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benefits of the study, which include assisting to further research concerning naloxone 
administration for those who have overdosed, the personal experience of participating in 
a research study, and being entered into a drawing for an Amazon gift card.  They were 
informed the potential risks of participating in the study, including costing 15 to 20 
minutes of their time and potential discomfort from the questions and exposure to the 
scenario.  This disclosure concluded by again thanking them for their participation in the 
study and by asking them to answer all questions to the best of their ability.  The 
conclusion of the disclosure also reminded participants that their participation in this 
study remained completely anonymous, and that it was voluntary and could be exited at 
any time.  Upon completion of data collection via REDCap, the researcher analyzed the 
data using SPSS.  
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CHAPTER 4: RESULTS 
A logistic regression was used to examine the relationship of the hypothesized 
predictor variables on the dichotomous criterion variable of administering or not 
administering naloxone in the vignette.  A logistic regression of a binary response 
variable (Y) on a continuous, normally distributed variable (X) with a sample size of 120 
completed surveys achieves 80% power at a 0.05 significance level.  
All information was collected via REDCap and entered into SPSS for analysis. 
Descriptive statistics were used to assess the age of the participants, annual household 
income, concern of legal and civil ramifications, and total scores on the TEQ, AS-SU and 
AOAS.  A Pearson correlation was used to assess the relationship between the decision to 
administer naloxone and participant predictor variables including sex, age, race, whether 
the participant had or knew someone with a substance abuse problem, whether the 
participant was aware of anyone who ever needed to be given naloxone, whether he or 
she was naloxone trained, whether those trained carried naloxone on a regular basis, area 
of study, annual household income, concern over legal ramifications, concern over civil 
ramifications, total TEQ score, total AS-SU score, and total AOAS score.  
Participant responses were dichotomized into either administer or not administer 
naloxone for the purposes of the logistic regression.  The participants who chose any 
other action (call 911, have someone else administer naloxone, etc.) were categorized 
into the “not administer” group.  The logistic regression was used to examine whether the 
independent variables could be used to predict the criterion variable.  The data were 
entered in a nonspecific order, using the SPSS “enter” function, and did not use a step-
wise data entry, as the variables were all thought to be of equal importance.  
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Sample Demographics 
A total of 129 participants met all inclusion criteria and completed the full survey 
and, therefore, were included in the analysis for the present study.  Of these participants, 
32 (24.8%) were male and 97 (75.2%) were female.  Participants’ ages ranged from 18 to 
65 with an mean of 23.80 (SD = 7.33; see Table 1).  Of the 129 participants, 115 (89.1%) 
were Caucasian, 2 (1.6%) were African American, 5 (3.9%) were Hispanic, and 7 (5.5%) 
described themselves as either Asian or Other.  Area of study was included in the 
demographic information collected.  The sample consisted of 22 (17.1%) nursing/biology 
students, 30 (23.3%) psychology/human studies students, 21 (16.3%) 
business/management/mathematics students, 5 (3.9%) trade/technical school students, 
and 35 (27.1%) “other” students.  Sixteen (12.4%) participants chose not to disclose their 
areas of study.  Annual household income ranged from $6,000.00 to $600,000.00 with a 
mean income of $80,269.61.  
Only 117 (90%) respondents chose to provide information regarding their 
experiences with naloxone.  Of those who chose to provide this information (117), 62 
(53.0%) reported either themselves, family members, or friends who have had problems 
with substance abuse, 55 (47.0%) reported they, family members, or friends did not 
experience problems with substance abuse, and 12 participants chose not to answer this 
question.  The same number of participants, 117 (90%), chose to disclose whether they 
have had personal experience with needing naloxone.  Of the 117 respondents, 98 
(83.8%) said they, family members, or friends have not needed naloxone, whereas 19 
(16.2%) reported either they, family members, or friends have been administered 
naloxone.  Finally, of the 117 participants who provided information regarding their 
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experiences with naloxone, 101 (86.3%) participants reported that they have not been 
trained in the proper administration of naloxone, and 16 (13.7%) reported they have had 
the recommended training in proper administration.  Of these 16 (13.7%) trained 
participants, only 2 (1.8%) respondents reported they carry naloxone with them regularly.  
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Table 1 
Sample Demographics  
Variable N (%) or M (SD) 
Gender  
    Male  
    Female  
 
Age (years)  
 
Ethnicity  
    White 
    African American  
    Hispanic  
    Other  
 
Area of Study  
    Nursing/ Biology  
    Psychology/Human Services  
    Business/Management/Mathematics 
    Trade/Technical  
    Other 
    Did Not Disclose  
 
Annual Household Income  
 
Experienced Problems with Substance Abuse  
    Yes 
    No 
 
Aware of the Purpose of Naloxone 
    Yes  
    No  
 
Needed Naloxone  
    Yes 
    No  
 
Been Trained in The Proper Administration 
of Naloxone  
    Yes 
    No 
 
    If Yes, Carry it with You  
        Yes  
        No  
        N/A 
 






115 (89.1%)  
2 (1.6%) 
5 (3.9%)  
7 (5.5%)  
 
 
22 (17.1%)  
30 (23.3%) 
21 (16.3%)  
5 (3.9%) 
35 (27.1%) 
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Bivariate Correlations  
To analyze a potential relationship between variables, bivariate correlations were 
computed for the 11 predictor variables (sex, age, race, problems with substance abuse, 
awareness of purpose of naloxone, history of needing naloxone, being naloxone trained, 
carrying naloxone if trained, TEQ score, AS-SU score, and AOAS score) and the 
dichotomized criterion variable (administering naloxone [Y/N]).  These analyses assisted 
in determining whether any of the predictor variables were not correlated with the 
criterion variables and, therefore, needed to be excluded from the regression.  
Additionally, this analysis served to find any instances of multicollinearity.  Table 2 
depicts significant associations that were identified between predictor and criterion 
variables.  
Significant associations were found between some of the predictors and the 
criterion variable, administering naloxone: TEQ score (R = .203, p > 0.05), AS-SU score 
(R = -.190, p > 0.05), and AOAS score (R = .208, p > 0.05).  There were statistically 
significant correlations between predictor variables, but these correlations were not 
strong enough to signal multicollinearity; therefore, the logistic regression was run 
without eliminating variables.  
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Table 2  
Bivariate Correlation Matrix of Predictors and Criterion Variable: Decision to 
Administer Naloxone  
 
 
Note:   ** Correlation is significant at the 0.01 level (2-tailed) 




Prior to the analysis, assumptions associated with regression including normality, 
linearity, homoscedasticity, and multicollinearity were evaluated.  The normality 
assumption was evaluated using the Shapiro-Wilks test and histograms.  A plot of 
standardized residuals versus predicted values was used to determine homoscedasticity.  
Multicollinearity was tested by examining bivariate correlations between all independent 
variables.  If any two variables were found to be highly correlated, a decision would have 
been made regarding which one to drop from the regression model.   
An exploratory analysis included the percentage of each response to provide 
information about the proportion of participants who would (a) administer naloxone, (b) 
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ask someone else to administer the naloxone, (c) call 911, (d) ensure another witness calls 
911, or (d) not get involved.   
A binomial logistic regression was performed to ascertain the predictive nature of 
empathy, stigma toward substance users and personal attributions toward substance use 
on the likelihood that participants would choose to administer naloxone in the event they 
encountered someone experiencing an overdose.  Linearity of the continuous variables 
with respect to the logit of the criterion variable was assessed via the Box-Tidwell 
procedure.  The logistic regression model was statistically significant, χ2(3) = 13.595, p < 
.004.  The model explained 14.0% (Nagelkerke R2) of the variance in decision to 
administer naloxone and correctly classified 61.7% of cases.  The positive predictive 
value was 73.2% and negative predictive value was 47.4%.  Of the three predictor 
variables, only one was statistically significant: TEQ score (as shown in Table 3).  




Table 3  
Logistic Regression Predicting Decision to Administer Naloxone  
 B SE Wald df p Odds Ratio 
TEQ 
Score  .11 .05 4.98 1 .03 1.12 
AS-SU 
Score  -.02 .02 1.25  1 .26 .98 
AOAS 
Score  .13 .07 3.77 1 .05 1.14 
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CHAPTER 5: DISCUSSION 
Interpretation and Implications 
Hypothesis 1.  It was hypothesized that participants with higher levels of 
empathy would be significantly more likely to administer naloxone.  The results of both 
the bivariate correlation and the logistic regression demonstrated a relationship between 
the level of empathy and the decision to administer naloxone.  The achieved statistical 
significance demonstrated a high level of empathy as a predictor of the decision to 
administer naloxone in the event a person encounters someone experiencing an opioid 
overdose.  These results provide support for the first hypothesis.  
Hypothesis 2.  It was hypothesized that participants with lower levels of stigma 
toward opioid users would be significantly more likely to administer naloxone.  The 
results of the bivariate correlation demonstrated an inverse relationship between the level 
of stigma and the decision to administer naloxone.  This would support the second 
hypothesis.  Upon further analysis, the logistic regression did not reach statistical 
significance.  Due to the results of the logistic regression, the second hypothesis was not 
supported, and a low level of stigma was not identified as a predictor of the decision to 
administer naloxone.  
Hypothesis 3.  It was hypothesized that participants with lower levels of concern 
regarding legal/civil ramifications would be significantly more likely to administer 
naloxone.  During preliminary analyses, the concern over both legal and civil 
ramifications was not found to be significantly correlated with the decision to administer 
naloxone.  Therefore, this variable was not included in the logistic regression.  Because 
of this, this hypothesis was not supported, and concern over legal/civil ramifications was 
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not determined to relate to the decision to administer naloxone in the event of an 
overdose.  
Hypothesis 4.  It was hypothesized that participants with significantly lower 
degrees of negative attribution toward those who use opioids would be more likely to 
administer naloxone.  The bivariate correlation demonstrated a relationship between the 
level of personal attribution toward substance use and the decision to administer 
naloxone.  The logistic regression demonstrated this relationship did not meet statistical 
significance (p = .052).  For this reason, hypothesis 4 was not supported, and personal 
attribution level was not considered to be a predictor of the decision to administer 
naloxone.  It is possible that with a higher power, this relationship would have yielded 
statistical significance and should be considered in further research.   
Interpretation of the results of this study indicates that of the four hypotheses, the 
variable that had the most significant impact on the decision to administer naloxone to 
someone overdosing on opioids was level of empathy, with people who have higher 
empathy being more likely to administer it.  It is important to note the measure used 
considered the general construct of empathy, not empathy toward those who use 
substances specifically.  
Although not statistically significant as predictors, both levels of stigma and 
levels of personal attribution were correlated with the decision to administer naloxone.  
This indicates that, although not predictive, low levels of stigma and personal attribution 
for substance abuse appear to be linked to the decision to administer naloxone.  
Finally, the concerns of legal and civil ramifications were not correlated with the 
decision to administer naloxone.  This means that there was no significant relationship 
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found between the level of concern of being charged with a crime or lawsuit and the 
ultimate decision of administering naloxone to someone experiencing an overdose.  
The implications of this study are vast.  The results of this study can be utilized to 
inform multiple facets of the efforts to use naloxone to save lives in the event of opioid 
overdoses.  This study may provide useful information regarding the degree to which 
individuals are willing to administer naloxone and factors that may influence this 
decision.  Knowledge about the factors that increase an individual’s likelihood of 
administering naloxone can be useful to many groups of people, such as policymakers, 
educators, and family counselors.  The information gathered in this study can be used to 
adapt programs to capitalize on these factors.  Since results indicate that level of empathy 
predicts the decision to utilize naloxone, training efforts should include material that is 
used to foster empathy.  Furthermore, because results support an inverse relationship 
between stigma and the decision to administer naloxone, those who work in the 
prevention field can direct their efforts toward fighting stigma.  The same can be said for 
the levels of personal attribution toward those with substance use problems: Training 
efforts can provide information that lowers the level of personal attribution and 
capitalizes on disseminating the disease concept of addiction to decrease beliefs 
concerning the overdosed persons’ choice to use drugs.  This same information can be 
utilized to empirically justify funding toward the aforementioned prevention efforts.  
In addition to providing insight into the administration of naloxone, the results of 
this study can inform the strategies of future public outreach programs for substance use 
and naloxone administration.  The factors that are associated with the decision to 
administer naloxone can be utilized to direct the efforts of those working in prevention.  
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The results of this study demonstrate that high empathy is correlated with the decision to 
administer naloxone; therefore, outreach efforts can be targeted toward the public’s 
empathy.  
Results measuring the degree of the endorsement of the disease concept cannot 
definitively identify whether the disease concept is permeating into the general public.  
The results demonstrate the sample in this study have some levels of personal attribution, 
indicating they may endorse a moralistic view of substance use; therefore, the results are 
indicative of the need for further education regarding the disease concept of addiction. 
Limitations 
The primary limitation of this study is the use of a convenience sample.  As such, 
the results of this study may only generalize to college students.  The decision to use a 
convenience sample was made with the acknowledgement of trading potential 
randomization and generalizability for a sample with similar ages, education levels, and 
exposure to contemporary teachings about substance use disorders.  Although 
socioeconomic data were collected, it was within a sample of college students and results 
may not generalize to low-education families.  In addition, other possible variables of 
interest were represented due to being missing from the demographic information.  For 
example, one variable that was not collected was previous legal history.  It is conceivable 
that those with legal histories may have more concern about legal ramifications if they 
have some sort of probation or parole indicating they are not to have interactions with the 
authorities.  It is also conceivable this higher level of concern may impact their decisions 
more than those who have no legal histories.  
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Additionally, the use of a vignette may impact the ecological validity of this 
study.  Because the vignette indicates the participant has had the training to carry 
naloxone, the reported likelihood of administration may be inflated.  This was mitigated 
by adding an item asking the participant to indicate how closely he or she believes his or 
her choice of action matches how he or she would respond in real life.  During the 
primary analyses, a correlation was not found between confidence ratings and decisions 
to administer naloxone (See Table 1).  This indicates that people’s actions may differ in 
real-life scenarios; however, it appears that participants took this into consideration due 
to the neutral nature of the mean of the responses.  This may be the result of high, yet not 
perfect, confidence in their chosen next courses of action.  Similarly, the use of self-
report measures may impact the validity of participant responses due to the potential 
presence of the Hawthorne effect. In future versions of this study, it may be helpful to 
include some measure of social desirability, such as the Marlowe-Crowne Social 
Desirability Scale, order to mitigate this limitation.  
The use of social media to collect data can be a limitation in interpreting these 
results.  Due to the nature of social media, inferences cannot be made about specific 
geographic or cultural regions.  Data collection via social media also requires the 
participants to answer honestly to the questions concerning the inclusion criterion and 
that each participant only took the survey one time.  A limitation identified after data 
collection included that the annual household income was not specified to being USD and 
could have been entered in another currency rate, which may impact the accuracy of the 
socioeconomic statuses represented in the sample.  
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Another limitation of this study is the use of an adapted measure to quantify the 
participant’s level of personal attribution toward those using opioids.  The adapted 
version of the Attributions of Obesity Scale has no established validity or reliability.  
Although this measure has not been validated to measure attitudes toward the substance 
using population, it is believed that items measure the same concepts with relation to a 
compulsive behavior.  After data collection, it was decided to not use the full adapted 
measure because some items did not fully measure the desired construct.  Instead, only 
four questions were used in the analysis: 1. Addiction is a chronic disease of the brain, 2. 
Most addicted people could stop using drugs if they were motivated to do so, 5, Medical 
care for addicted patients without any other medication conditions should be covered by 
healthcare, and 11. It is difficult to feel empathy for an addicted person.  These items 
were chosen as it was deemed their answers would measure the level of personal 
attribution that would equate to endorsing either the disease concept or moral model.  
Due to the lack of psychometrics on this measure, it is plausible that the biases of the 
researchers impacted the chosen items.  
Additionally, there are only two items that measured the participants’ concern 
regarding the potential for legal/civil ramifications.  The lack of items measuring this 
concept may mean that the construct was not accurately measured as a factor in the 
participants’ decision whether to administer naloxone in the vignette.  
Furthermore, the choice provided could have dichotomized the participants’ 
options to either help or not help the encountered individual.  The decision was made to 
provide additional responses to learn more about the various degrees of help a participant 
would choose to provide.  
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The formatting of this survey can be considered a limitation.  The present study 
used an adapted version of the Attributions of Obesity Scale (Foster et al., 2003).  The 
final section of this measure included a semantic differential scale that did not include 
anchors.  This format did not seemlessly transfer into the REDcap software, which could 
have potentially caused confusion for the participants.  Similarly, the entire survey 
consisted of 69 items.  Upon analyzing the data, it was found that 233 participants started 
the survey, yet only 128 surveys were able to be analyzed.  The remainder of the surveys 
were not able to be analyzed due to not being completed.  Future adapatations of this 
study may benefit from condensing items to have a higher completion rate of responses.  
Future Directions 
Future variations of this study should be completed with varying populations. 
Assessing the likelihood of naloxone administration is important among non-student 
adults, first-responders, newly trained individuals, college staff, and beyond.  Each group 
possesses unique qualities that may impact their decisions to utilize naloxone should they 
encounter an overdosed person.  Future research with various populations would allow 
for further development in the efforts to expand the carrying and utilization of naloxone.  
These results can be used to assess and develop various training methods for 
opioid overdose recognition and naloxone administration.  Future studies can take the 
results of the present study and assess training efforts and ensure they are capitalizing on 
the characteristics that will contribute to trainees’ decisions to use naloxone.  It would 
also be beneficial to assess the factors that contribute to an individual’s decision to 
become trained in naloxone.  
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Considering results indicate empathy as a predictor of the decision to administer 
naloxone, it would be imperative for future research to examine how to build empathy for 
those afflicted with substance use disorders and implement those results into training 
strategies.  The knowledge gained in this study could change the modalities of naloxone 
training to foster empathy and increase the likelihood that the participants of trainings 
will carry and use naloxone should they encounter someone who has overdosed.  
The knowledge that empathy is an indicator of someone choosing to administer 
naloxone can be a helpful tool in clinical situations.  This information can be used to 
increase empathy in family members of those seeking treatment for OUD.  If family 
members have empathy for a newly discharged patient, they have the potential to accept 
the recommendation of keeping naloxone in their homes to use in the event of a relapse.  
The results of this study can be used to inform future policy.  Identifying factors 
that increase the likelihood of individuals carrying and utilizing naloxone may help 
policymakers more effectively develop strategies to combat deaths caused by opioid 
overdose.  Informed and effective policies can change public perceptions regarding 
opioid addiction.  Reducing public stigma can help addiction to be viewed the same as 
other chronic relapsing conditions, such as diabetes and asthma, and pave the way for 
naloxone to be as visible and accessible as a defibrillator.  Greater accessibility to 
naloxone will greatly increase public safety and reduction of opioid deaths.  
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1. Biological Sex:   Male____  Female____ 
 
2. Are you 18 years of age or older? Yes____ No____  
 
3. Age (in years):   
 
4. Race/Ethnicity:  
 
a.  White 
b.  Black or African American 
c. Hispanic, Spanish, or Latino 
d.  American Indian or Alaskan Native 
e.  Asian 
f. Native Hawaiian or Pacific Islander 
g. Other 
 
5. Are you currently enrolled in an undergraduate or trade school program? Yes ___ 
No___  
 
6. Area of Study/College Major:________________ 
 
7. Household income past year (if you live with your parent/guardian when school is 
not in session, include their income):_________  
 
8. Have you, a family member, or friend experienced problems with substance use 
or misuse? Yes____ No____  
 
9. Are you aware of the purpose of naloxone (i.e., Narcan/Evzio)?  Yes____ 
No____  
 
10. Have you, a family member, or friend ever needed to be given naxolone 
(Narcan/Evzio)?  Yes____ No____  
 
11. Are you currently trained in the proper administration of naloxone (i.e., 
Narcan/Evzio)?  Yes____ No____  
 
12. If yes, do you carry it with you regularly Yes____ No____ Not Applicable _____ 
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APPENDIX B 
Vignette 
Please read the following vignette and respond to the corresponding item to 
indicate your next course of action.  
 
You have been trained on the proper administration of naloxone, a nasal spray 
designed to reverse the effects of an opioid overdose.  You also learned that the 
medication has no adverse effects even if used with someone who is not experiencing an 
overdose.  You have 1 dose with you in your backpack.  As you are traveling to class, 
you decide to stop in a convenience store to buy a cup of coffee and use the restroom. 
When you enter the convenience store, there are a few other customers in addition to the 
clerk. Upon entering the restroom, you notice a person sitting on the floor in the corner of 
the room. The person is slumped over on the floor and is breathing so slowly that it is 
almost hard to tell if they are breathing at all. They do not respond when you ask if they 
are feeling ok, and you see their lips are beginning to turn a shade of blue. You then see 
marks on their arm and immediately recognize this as an opioid overdose.  
 
Please indicate your next course of action:  
(1) administer naloxone by spraying a partial dose in each nostril 
(2) ask another customer to administer the naloxone  
(3) call 911 yourself without administering naloxone 
(4) ensure another witness calls 911  





How confident are you, on a scale of 1-5 (1 being not confident and 5 being completely 
confident) that you would definitely follow this course of action in real life?       
     Not                                  Completely 
Confident                    Confident  
 
1    2      3      4      5 
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APPENDIX C 
Concern Over Legal/Civil Ramifications 
Please indicate, on a scale of 1-5 (1 being did not influence and 5 being 
completely influenced) the degree to which your concerns about potential legal 
ramifications (being charged with a crime) may have influenced the course of action you 
took in the previous scenario. 
 
Did Not            Completely 
Influence             Influenced 
 
       1  2  3  4  5 
 
 
Please indicate on a scale of 1-5, (1 being did not influence and 5 being 
completely influenced) the degree to which your concerns about potential civil 
ramifications (being subject to a lawsuit) may have influenced the course of action you 
took in the previous scenario.  
 
Did Not             Completely 
Influence              Influenced 
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APPENDIX D 
Toronto Empathy Questionnaire 
Below is a list of statements.  Please read each statement carefully and rate how 
frequently you feel or act in the manner described.  Circle your answer on the response 
form.  There are no right or wrong answers or trick questions.  Please answer each 
question as honestly as you can.  
 
  Never Rarely Sometimes Often 
 
Always 
1. When someone else is feeling excited, 
I tend to get excited too  
0 1 2 3 4 
2. Other people's misfortunes do not 
disturb me a great deal  
0 1 2 3 4 
3. It upsets me to see someone being 
treated disrespectfully  
0 1 2 3 4 
4. I remain unaffected when someone 
close to me is happy  
0 1 2 3 4 
5. I enjoy making other people feel better  0 1 2 3 4 
6. I have tender, concerned feelings for 
people less fortunate than me  
0 1 2 3 4 
7. When a friend starts to talk about 
his\her problems, I try to steer the 
conversation towards  
something else  
0 1 2 3 4 
8. I can tell when others are sad even 
when they do not say anything 
0 1 2 3 4 
9. I find that I am "in tune" with other 
people's moods 
0 1 2 3 4 
10. I do not feel sympathy for people who 
cause their own serious illnesses  
0 1 2 3 4 
11. I become irritated when someone cries  0 1 2 3 4 
12. I am not really interested in how other 
people feel 
0 1 2 3 4 
13. I get a strong urge to help when I see 
someone who is upset 
0 1 2 3 4 
14. When I see someone being treated 
unfairly, I do not feel very much pity 
for them 
0 1 2 3 4 
15. I find it silly for people to cry out of 
happiness  
0 1 2 3 4 
16. When I see someone being taken 
advantage of, I feel kind of protective 
towards him\her 
0 1 2 3 4 
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APPENDIX E 
Affect Scale for Substance Users (AS-SU) 
Indicate how you would feel if you interacted with someone with an opioid use 
disorder?  
 
Pessimistic 1 2 3 4 5 6 7 Optimistic 
Tranquil 1 2 3 4 5 6 7 Anxious 
Supportive 1 2 3 4 5 6 7 Resentful 
Fearful  1 2 3 4 5 6 7 Confident  
Empathic 1 2 3 4 5 6 7 Angry 
Disgusted 1 2 3 4 5 6 7 Sympathetic 
Apprehensive 1 2 3 4 5 6 7 Comfortable 
Irritable 1 2 3 4 5 6 7 Patient 
Relaxed 1 2 3 4 5 6 7 Tense 
Calm  1 2 3 4 5 6 7 Nervous 
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APPENDIX F: 
Attributions of Addiction Scale 
Using the following scale, please indicate the degree to which you agree or 
disagree with the statements below.  
 
1 – Strongly Disagree     2 – Disagree     3 – Neutral     4- Agree      5 – Strongly Agree 
 
 
___ Addiction is a chronic disease associated with differences in the brain. 
___ Most addicted people could stop using drugs if they were motivated to do so. 
___ I have negative reactions toward addicted people based on their appearance. 
___ I am obligated to educate addicted people on the health risks of using drugs. 
___ Medical care for addicted patients without any other medical conditions  
       should be  
       covered by health care. 
___ For most people addicted to drugs, long-term abstinence is impossible.  
___ Addicted persons are well aware of the health risks of drug use.  
___ I often feel uncomfortable when interacting with an addicted person.  
___ Most drug addicted persons will not become abstinent.  
___ It does not hurt to apply “scare tactics” to encourage addicted persons to  
       convince them to stop using drugs.  
___ It is difficult to feel empathy for an addicted person.  
___ I feel like I have a good understanding of how someone becomes addicted.  
 
Listed below are adjective sometimes used to describe addicted people.  
Please indicate your beliefs about addicted people. 
 
Successful            __ : __ : __ : __ : __ : __ : __      Unsuccessful 
Weak-willed         __ : __ : __ : __ : __ : __ : __    Strong-Willed 
Handsome              __ : __ : __ : __ : __ : __ : __                Ugly 
Graceful                   __ : __ : __ : __ : __ : __ : __        Awkward 
Dirty                    __ : __ : __ : __ : __ : __ : __                 Clean 
Pleasant                __ : __ : __ : __ : __ : __ : __         Unpleasant 
Dishonest               __ : __ : __ : __ : __ : __ : __              Honest 
Warm                      __ : __ : __ : __ : __ : __ : __                Cold 
Bad                __ : __ : __ : __ : __ : __ : __                  Good 
Sloppy                __ : __ : __ : __ : __ : __ : __               Neat 
Compliant            __ : __ : __ : __ : __ : __ : __     Noncompliant 
Hard to talk to       __ : __ : __ : __ : __ : __ : __    Easy to talk to 
Attractive               __ : __ : __ : __ : __ : __ : __      Unattractive 
Lazy                    __ : __ : __ : __ : __ : __ : __         Industrious 
Likeable                 __ : __ : __ : __ : __ : __ : __     Not Likeable 
 
 
 
  
 
